Salivary LINC00657 as a Diagnostic Biomarker for Oral Squamous Cell Carcinoma
NCT ID: NCT05821179
Last Updated: 2023-04-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
36 participants
OBSERVATIONAL
2022-01-01
2023-02-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Long Non Coding MALAT1 as a Potential Salivary Diagnostic Biomarker in Oral Squamous Cell Carcinoma Through Targeting mi RNA 124
NCT05708209
Verification of Saliva MMP-1 as a Diagnostic Marker of Oral Cavity Cancer
NCT05049408
Biomarkers for Oral Cancer
NCT00341497
Assessment of Bmi-1 on Protein and Molecular Levels in Oral Dysplasia and Squamous Cell Carcinoma: A Diagnostic Study
NCT03345966
Epigenetic Biomarkers in the Saliva for the Diagnosis of Squamous Cells Carcinoma of the Oral Cavity
NCT05791149
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group I
12 patients diagnosed with OSCC.
No interventions assigned to this group
Group II
12 patients diagnosed with OLP.
No interventions assigned to this group
Group III
12 systemically free individuals with no oral mucosal lesions.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* group II: oral lichen planus lesions (OLP)
* group III: systemically healthy volunteers
Exclusion Criteria
* any oral lesion in group III
* pregnant females
20 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fayoum University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nayroz Tarrad
associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nayroz Tarrad, as. professor
Role: PRINCIPAL_INVESTIGATOR
faculty of dentistry, Fayoum university
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
faculty of dentistry, Fayoum university
Al Fayyum, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Tarrad NAF, Hassan S, Shaker OG, AbdelKawy M. "Salivary LINC00657 and miRNA-106a as diagnostic biomarkers for oral squamous cell carcinoma, an observational diagnostic study". BMC Oral Health. 2023 Dec 12;23(1):994. doi: 10.1186/s12903-023-03726-0.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
M1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.